Amgen Inc: (NASD: AMGN)
$99.08
1.66 (1.70%)
Volume 3,058,886
Jun 17 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Comparison to Industry
Industry / Sector Report
Industry: MED-BIOMED/GENE
Zacks Industry Rank: 
Rank in Industry:
Recommendations and Estimates
| Company | Industry | SP500 | |
|---|---|---|---|
| Average Recommendation (1=Buy, 5=Sell) | 2.18 | 1.62 | 9.99 |
| Current Quarter Estimate | 1.68 | 1.97 | 25.88 |
| Year Ago Quarter Estimate | 1.82 | 1.90 | 24.24 |
| Next Quarter Estimate | 1.73 | 2.12 | 26.63 |
| Next Year Estimate | 8.22 | 1.51 | 25.43 |
Growth Rates
| Company | Industry | SP500 | |
|---|---|---|---|
| This Year (11.6) | 11.60 | 6.20 | 11.40 |
| Next Year (14.3) | 14.30 | 15.50 | 6.50 |
| Last 5 Years | 9.20 | 17.50 | 5.70 |
| Next 5 Years | 8.40 | 17.20 | NA |
Financials
| Company | Industry | ||
|---|---|---|---|
| Price/Earnings (TTM) | 14.26 | -9.85 | |
| Price/Book (MRQ) | 3.74 | 3.82 | |
| Price/Cash Flow (MRFY) | 12.13 | 18.62 | |
| Dividend Yield | 1.93% | 0.00% | |
| Net Profit Margin (TTM) | 26.33% | -153.28% | |
| Return on Equity (TTM) | 27.36% | -61.13% | |
| Debt to Equity (MRQ) | 1.23 | 0.02 |
MRQ = Most Recent Quarter TTM = Trailing Twelve Months MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.
